NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00738751 2015-02-04Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Completed44 enrolled